The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital… (NCT07351435) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique
1,200 participantsStarted 2026-02-01
Plain-language summary
The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing VV, VA or VAV ECMO implantation in the French West Indies and Guiana. All patients undergoing ECMO implantation will be prospectively registered.
Who can participate
Age range
90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All consecutive patients implanted with a veno-venous extracorporeal membrane oxygenation device or extracorporeal membrane oxygenation device by the HeartTeam from the University Hospital of Martinique (UHM) from January 2010
Exclusion Criteria:
* Patients with incomplete data (primary endpoint and less than 80% secondary study outcomes)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This registry is based at a hospital in Martinique — if I'm not already a patient there, is this study even a realistic option for me to discuss, or would my care happen somewhere else?
2Since this study is a registry tracking ECMO outcomes rather than testing a new treatment, does participating mean my actual care would change in any way, or would it mainly involve my data being recorded?
3The primary thing this registry is measuring is whether patients survive to 30 days — what does my doctor think my own 30-day outlook looks like with or without ECMO, based on my specific condition?
4This study covers a wide range of serious conditions like cardiac arrest, ARDS, and sepsis — given which condition applies to me, does my doctor think ECMO is even being considered as part of my treatment plan right now?
5Since this registry is not yet recruiting, is there a meaningful delay before it opens, and in the meantime, what are the standard-of-care options my doctor recommends for my situation rather than waiting?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Mortality at 30 days
Timeframe: from canula implantation to 30 days afterwards